Prevalence of transmitted HIV-1 drug resistance in HIV-1-infected patients in Italy: evolution over 12 years and predictors | Zendy

Laura Bracciale | Zendy; Manuela Colafigli | Zendy; Maurizio Zazzi | Zendy; Paola Corsi | Zendy; Paola Meraviglia | Zendy; Valeria Micheli | Zendy; Renato Maserati | Zendy; Nicola Gianotti | Zendy; Giovanni Penco | Zendy; Maurizio Setti | Zendy; Simona Di Giambenedetto | Zendy; Luca Butini | Zendy; A Vivarelli | Zendy; Michele Trezzi | Zendy; Andrea De Luca | Zendy

Open Access

Prevalence of transmitted HIV-1 drug resistance in HIV-1-infected patients in Italy: evolution over 12 years and predictors

Author(s) -

Laura Bracciale,

Manuela Colafigli,

Maurizio Zazzi,

Paola Corsi,

Paola Meraviglia,

Valeria Micheli,

Renato Maserati,

Nicola Gianotti,

Giovanni Penco,

Maurizio Setti,

Simona Di Giambenedetto,

Luca Butini,

A Vivarelli,

Michele Trezzi,

Andrea De Luca

Publication year - 2009

Publication title -

journal of antimicrobial chemotherapy

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.124

H-Index - 194

eISSN - 1460-2091

pISSN - 0305-7453

DOI - 10.1093/jac/dkp246

Subject(s) - reverse transcriptase , drug resistance , nucleoside reverse transcriptase inhibitor , virology , medicine , reverse transcriptase inhibitor , hiv drug resistance , odds ratio , viral load , antiretroviral therapy , human immunodeficiency virus (hiv) , biology , polymerase chain reaction , microbiology and biotechnology , genetics , gene

Transmitted HIV-1 drug resistance (TDR) can reduce the efficacy of first-line antiretroviral therapy.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research